Table 2. The percentages of CD3+, CD3+CD4+, CD3+CD8+in each group (M ± SD, n = 6, unit = %).
| Parameters | RVC | RDSL | RDSM | RDSH | MI |
|---|---|---|---|---|---|
| CD3+ | 62.23±3.11 | 66.23±1.81 | 62.40±10.76 | 64.56±8.85 | 65.46±5.23 |
| CD3+CD4+ | 23.40±5.06 | 28.83±3.91 | 24.23±4.60 | 30.40±3.73 | 27.70±4.49 |
| CD3+CD8+ | 20.53±4.35 | 21.03±3.93 | 18.23±4.44 | 18.60±1.47 | 18.10±3.47 |
| CD4+/CD8+1 | 1.14±0.13 | 1.41±0.37 | 1.39±0.52 | 1.63±0.19* | 1.54±0.14* |
RVC, rotavirus control group; RDSL, low dose of resveratrol dry suspension group (3mg/kg/day); RDSM, medium dose of resveratrol dry suspension group (10mg/kg/day); RDSH, high dose of resveratrol dry suspension group (30mg/kg/day); MI, mock infected group.
* Represents significant difference compared with the RVC group (independent-samples t test, P < 0.05)
+ Represents significant difference compared with the MI group (independent-samples t test, P < 0.05)
1 The parameter has no unit.